Journal of the Neurological Sciences
Volume 288, Issue 1 , Pages 13-24 , 15 January 2010

Penumbra, the basis of neuroimaging in acute stroke treatment: Current evidence

  • Gyanendra Kumar

      Affiliations

    • Department of Neurology, University of Missouri-Healthcare Columbia, Columbia, CE 507 Five Hospital Drive, Columbia, Missouri, 65212, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 573 882 4141; fax: +1 573 884 4249.
    • ,
  • Munish Kumar Goyal

      Affiliations

    • Department of Neurology, University of Missouri-Healthcare Columbia, Columbia, CE 507 Five Hospital Drive, Columbia, Missouri, 65212, USA
    • ,
  • Pradeep Kumar Sahota

      Affiliations

    • Department of Neurology, University of Missouri-Healthcare Columbia, Columbia, CE 507 Five Hospital Drive, Columbia, Missouri, 65212, USA
    • ,
  • Rajan Jain

      Affiliations

    • Department of Radiology, Division of Neuroradiology, Henry Ford Hospital, Detroit, Michigan, USA

Received 12 June 2009 ,Revised 6 August 2009 ,Accepted 23 September 2009.

References 

  1. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655–1711May
  2. Hossmann KA. Neuronal survival and revival during and after cerebral ischemia. Am J Emerg Med. 1983;1(2):191–197
  3. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36(4):557–565
  4. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia — the ischemic penumbra. Stroke. 1981;12(6):723–725
  5. Pialat JB, Wiart M, Nighoghossian N, Adeleine P, Derex L, Hermier M, et al. Evolution of lesion volume in acute stroke treated by intravenous t-PA. J Magn Reson Imaging. 2005;22(1):23–28
  6. Read SJ, Hirano T, Abbott DF, Markus R, Sachinidis JI, Tochon-Danguy HJ, et al. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol. 2000;48(2):228–235
  7. Rowley HA. The four Ps of acute stroke imaging: parenchyma, pipes, perfusion, and penumbra. AJNR Am J Neuroradiol. 2001;22(4):599–601
  8. Baron JC. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis. 2001;11(Suppl 1):2–8
  9. Hunter GJ, Silvennoinen HM, Hamberg LM, Koroshetz WJ, Buonanno FS, Schwamm LH, et al. Whole-brain CT perfusion measurement of perfused cerebral blood volume in acute ischemic stroke: probability curve for regional infarction. Radiology. 2003;227(3):725–730
  10. Wintermark M, Reichhart M, Thiran JP, Maeder P, Chalaron M, Schnyder P, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol. 2002;51(4):417–432
  11. Kaufmann AM, Firlik AD, Fukui MB, Wechsler LR, Jungries CA, Yonas H. Ischemic core and penumbra in human stroke. Stroke. 1999;30(1):93–99
  12. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000;20(9):1276–1293
  13. Heiss WD, Kracht LW, Thiel A, Grond M, Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain. 2001;124(Pt 1):20–29
  14. Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, et al. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology. 1998;51(6):1617–1621
  15. Sobesky J, Zaro Weber O, Lehnhardt FG, Hesselmann V, Thiel A, Dohmen C, et al. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke. 2004;35(12):2843–2847
  16. Hamon M, Marie RM, Clochon P, Coskun O, Constans JM, Viader F, et al. Quantitative relationships between ADC and perfusion changes in acute ischemic stroke using combined diffusion-weighted imaging and perfusion MR (DWI/PMR). J Neuroradiol. 2005;32(2):118–124
  17. Dewar D, Yam P, McCulloch J. Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol. 1999;375(1–3):41–50
  18. Falcao AL, Reutens DC, Markus R, Koga M, Read SJ, Tochon-Danguy H, et al. The resistance to ischemia of white and gray matter after stroke. Ann Neurol. 2004;56(5):695–701
  19. Koga M, Reutens DC, Wright P, Phan T, Markus R, Pedreira B, et al. The existence and evolution of diffusion–perfusion mismatched tissue in white and gray matter after acute stroke. Stroke. 2005;36(10):2132–2137
  20. Simon JE, Bristow MS, Lu H, Lauzon ML, Brown RA, Manjon JV, et al. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. J Cereb Blood Flow Metab. 2005;25(9):1236–1243
  21. Bristow MS, Simon JE, Brown RA, Eliasziw M, Hill MD, Coutts SB, et al. MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab. 2005;25(10):1280–1287
  22. Ebinger M, De Silva DA, Christensen S, Parsons MW, Markus R, Donnan GA, et al. Imaging the penumbra — strategies to detect tissue at risk after ischemic stroke. J Clin Neurosci. 2009;16(2):178–187
  23. Hossmann KA. Cerebral ischemia: models, methods and outcomes. Neuropharmacology. 2008;55(3):257–270
  24. Montavont A, Nighoghossian N, Derex L, Hermier M, Honnorat J, Philippeau F, et al. Intravenous r-TPA in vertebrobasilar acute infarcts. Neurology. 2004;62(10):1854–1856
  25. Ostrem JL, Saver JL, Alger JR, Starkman S, Leary MC, Duckwiler G, et al. Acute basilar artery occlusion: diffusion–perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke. 2004;35(2):e30–e34
  26. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36(7):1432–1438
  27. De Silva DA, Fink JN, Christensen S, Ebinger M, Bladin C, Levi CR, et al. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke. 2009;40(8):2872–2874
  28. Sasaki O, Takeuchi S, Koizumi T, Koike T, Tanaka R. Complete recanalization via fibrinolytic therapy can reduce the number of ischemic territories that progress to infarction. AJNR Am J Neuroradiol. 1996;17(9):1661–1668
  29. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36(1):66–73
  30. Soares BP, Chien JD, Wintermark M. MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke. 2009 Mar;40(3 Suppl):S24-7.
  31. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke. 1995;26(12):2219–2221
  32. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999;9(4):193–201
  33. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke. 1999;30(10):2043–2052
  34. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768–774
  35. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282(21):2019–2026
  36. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017–1025
  37. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J, et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke. 2006;37(3):852–858
  38. Kaste M. Reborn workhorse, CT, pulls the wagon toward thrombolysis beyond 3hours. Stroke. 2004;35(2):357–359
  39. Ribo M, Molina CA, Rovira A, Quintana M, Delgado P, Montaner J, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke. 2005;36(3):602–606
  40. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52(1):20–28
  41. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34(9):2208–2214
  42. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36(8):1705–1709
  43. Ay H, Koroshetz WJ, Vangel M, Benner T, Melinosky C, Zhu M, et al. Conversion of ischemic brain tissue into infarction increases with age. Stroke. 2005;36(12):2632–2636
  44. Allport LE, Parsons MW, Butcher KS, MacGregor L, Desmond PM, Tress BM, et al. Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology. 2005;65(9):1382–1387
  45. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36(4):797–802
  46. Nakajima S, Meyer JS, Amano T, Shaw T, Okabe T, Mortel KF. Cerebral vasomotor responsiveness during 100% oxygen inhalation in cerebral ischemia. Arch Neurol. 1983;40(5):271–276
  47. Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke. 1992;23(3):317–324
  48. Bastianello S, Pierallini A, Colonnese C, Brughitta G, Angeloni U, Antonelli M, et al. Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology. 1991;33(3):207–211
  49. von Kummer R, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol. 1994 Jan;15(1):9–15; discussion 6–8.
  50. Tomsick TA, Brott TG, Olinger CP, Barsan W, Spilker J, Eberle R, et al. Hyperdense middle cerebral artery: incidence and quantitative significance. Neuroradiology. 1989;31(4):312–315
  51. von Kummer R, Holle R, Gizyska U, Hofmann E, Jansen O, Petersen D, et al. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. AJNR Am J Neuroradiol. 1996;17(9):1743–1748
  52. Tomura N, Uemura K, Inugami A, Fujita H, Higano S, Shishido F. Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. Radiology. 1988;168(2):463–467
  53. Truwit CL, Barkovich AJ, Gean-Marton A, Hibri N, Norman D. Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology. 1990;176(3):801–806
  54. Lev MH, Farkas J, Gemmete JJ, Hossain ST, Hunter GJ, Koroshetz WJ, et al. Acute stroke: improved nonenhanced CT detection—benefits of soft-copy interpretation by using variable window width and center level settings. Radiology. 1999;213(1):150–155
  55. Dippel DW, Du Ry van Beest Holle M, van Kooten F, Koudstaal PJ. The validity and reliability of signs of early infarction on CT in acute ischaemic stroke. Neuroradiology. 2000;42(9):629–633
  56. Schriger DL, Kalafut M, Starkman S, Krueger M, Saver JL. Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy. JAMA. 1998;279(16):1293–1297
  57. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke. 1999;30(8):1528–1533
  58. Wardlaw JM, Dorman PJ, Lewis SC, Sandercock PA. Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT?. J Neurol Neurosurg Psychiatry. 1999;67(5):651–653
  59. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001;22(8):1534–1542
  60. Katz DA, Marks MP, Napel SA, Bracci PM, Roberts SL. Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology. 1995;195(2):445–449
  61. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol. 1994;15(10):1817–1822
  62. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology. 1993;35(2):159–162
  63. Roberts HC, Dillon WP, Furlan AJ, Wechsler LR, Rowley HA, Fischbein NJ, et al. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke. 2002;33(6):1557–1565
  64. Tountopoulou A, Ahl B, Weissenborn K, Becker H, Goetz F. Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation. Neuroradiology. 2008 Jan;50(1):75–83
  65. Maruya J, Yamamoto K, Ozawa T, Nakajima T, Sorimachi T, Kawasaki T, et al. Simultaneous multi-section perfusion CT and CT angiography for the assessment of acute ischemic stroke. Acta Neurochir (Wien). 2005 Apr;147(4):383–91; discussion 91–2.
  66. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37(4):979–985
  67. Wintermark M, Meuli R, Browaeys P, Reichhart M, Bogousslavsky J, Schnyder P, et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology. 2007;68(9):694–697
  68. Muir KW, Halbert HM, Baird TA, McCormick M, Teasdale E. Visual evaluation of perfusion computed tomography in acute stroke accurately estimates infarct volume and tissue viability. J Neurol Neurosurg Psychiatry. 2006;77(3):334–339
  69. Eastwood JD, Lev MH, Wintermark M, Fitzek C, Barboriak DP, Delong DM, et al. Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. AJNR Am J Neuroradiol. 2003;24(9):1869–1875
  70. Hellier KD, Hampton JL, Guadagno JV, Higgins NP, Antoun NM, Day DJ, et al. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry. 2006;77(3):417–419
  71. Launes J, Ketonen L. Dense middle cerebral artery sign: an indicator of poor outcome in middle cerebral artery area infarction. J Neurol Neurosurg Psychiatry. 1987 Nov;50(11):1550–1552
  72. New PF, Aronow S. Attenuation measurements of whole blood and blood fractions in computed tomography. Radiology. 1976;121(3 Pt. 1):635–640Dec
  73. Stejskal E, Tanner J. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys. 1965;41:288
  74. Kucinski T, Vaterlein O, Glauche V, Fiehler J, Klotz E, Eckert B, et al. Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. Stroke. 2002;33(7):1786–1791
  75. Mohr JP, Biller J, Hilal SK, Yuh WT, Tatemichi TK, Hedges S, et al. Magnetic resonance versus computed tomographic imaging in acute stroke. Stroke. 1995;26(5):807–812
  76. Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, Rordorf G, et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6hours of stroke symptom onset. Radiology. 1999;210(1):155–162
  77. Mullins ME, Schaefer PW, Sorensen AG, Halpern EF, Ay H, He J, et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology. 2002;224(2):353–360
  78. Yoneda Y, Tokui K, Hanihara T, Kitagaki H, Tabuchi M, Mori E. Diffusion-weighted magnetic resonance imaging: detection of ischemic injury 39minutes after onset in a stroke patient. Ann Neurol. 1999;45(6):794–797
  79. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30(6):1174–1180
  80. Gass A, Ay H, Szabo K, Koroshetz WJ. Diffusion-weighted MRI for the “small stuff”: the details of acute cerebral ischaemia. Lancet Neurol. 2004;3(1):39–45
  81. Schaefer PW, Hunter GJ, He J, Hamberg LM, Sorensen AG, Schwamm LH, et al. Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol. 2002;23(10):1785–1794
  82. Ay H, Buonanno FS, Rordorf G, Schaefer PW, Schwamm LH, Wu O, et al. Normal diffusion-weighted MRI during stroke-like deficits. Neurology. 1999;52(9):1784–1792
  83. Senn P, Lovblad KO, Zutter D, Bassetti C, Zeller O, Donati F, et al. Changes on diffusion-weighted MRI with focal motor status epilepticus: case report. Neuroradiology. 2003;45(4):246–249
  84. Taleb M, Lovblad KO, El-Koussy M, Guzman R, Bassetti C, Arnold M, et al. Reperfusion demonstrated by apparent diffusion coefficient mapping after local intra-arterial thrombolysis for ischaemic stroke. Neuroradiology. 2001;43(7):591–594
  85. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology. 1999;52(9):1792–1798
  86. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47(4):462–469
  87. Lansberg MG, Tong DC, Norbash AM, Yenari MA, Moseley ME. Intra-arterial rtPA treatment of stroke assessed by diffusion- and perfusion-weighted MRI. Stroke. 1999;30(3):678–680
  88. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke. 2000;31(6):1318–1328
  89. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet. 1999;353(9169):2036–2037
  90. Fiehler J, Knudsen K, Kucinski T, Kidwell CS, Alger JR, Thomalla G, et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke. 2004;35(2):514–519
  91. Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology. 1997;49(1):113–119
  92. Oppenheim C, Grandin C, Samson Y, Smith A, Duprez T, Marsault C, et al. Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke?. Stroke. 2001;32(11):2486–2491
  93. Oppenheim C, Samson Y, Dormont D, Crozier S, Manai R, Rancurel G, et al. DWI prediction of symptomatic hemorrhagic transformation in acute MCA infarct. J Neuroradiol. 2002;29(1):6–13
  94. Atlas SW. Magnetic Resonance Imaging of the Brain and Spine. 4 ed. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer business; 2009.
  95. Fiebach JB, Schellinger PD, Gass A, Kucinski T, Siebler M, Villringer A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35(2):502–506
  96. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004;292(15):1823–1830
  97. Wiesmann M, Mayer TE, Yousry I, Medele R, Hamann GF, Bruckmann H. Detection of hyperacute subarachnoid hemorrhage of the brain by using magnetic resonance imaging. J Neurosurg. 2002;96(4):684–689
  98. Fiebach JB, Schellinger PD, Geletneky K, Wilde P, Meyer M, Hacke W, et al. MRI in acute subarachnoid haemorrhage; findings with a standardised stroke protocol. Neuroradiology. 2004;46(1):44–48
  99. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 2002;33(1):95–98
  100. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20(4):637–642
  101. Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging. 2005;22(4):439–450
  102. Wycliffe ND, Choe J, Holshouser B, Oyoyo UE, Haacke EM, Kido DK. Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging. 2004;20(3):372–377
  103. Petersen ET, Zimine I, Ho YC, Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol. 2006;79(944):688–701
  104. Bammer R, Skare S, Newbould R, Liu C, Thijs V, Ropele S, et al. Foundations of advanced magnetic resonance imaging. NeuroRx. 2005;2(2):167–196
  105. Kidwell CS, Alger JR, Saver JL. Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke. 2004;35(11 Suppl 1):2662–2665
  106. Chalela JA, Kang DW, Luby M, Ezzeddine M, Latour LL, Todd JW, et al. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol. 2004;55(1):105–112
  107. Latchaw RE, Yonas H, Hunter GJ, Yuh WT, Ueda T, Sorensen AG, et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke. 2003;34(4):1084–1104
  108. Uno M, Harada M, Yoneda K, Matsubara S, Satoh K, Nagahiro S. Can diffusion- and perfusion-weighted magnetic resonance imaging evaluate the efficacy of acute thrombolysis in patients with internal carotid artery or middle cerebral artery occlusion? Neurosurgery. 2002 Jan;50(1):28–34; discussion -5.
  109. Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3h time window after stroke onset: a cohort study. Lancet Neurol. 2006;5(8):661–667
  110. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–1329
  111. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet. 1998;352(9136):1245–1251
  112. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, et al. The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials. 2008;9(1):37
  113. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60(5):508–517
  114. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9hours after stroke onset. Stroke. 2006;37(5):1227–1231
  115. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009;8(2):141–150
  116. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7(4):299–309
  117. Warach S, Butman JA, Davis L, et al., editors. ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation (ROSIE): interim safety and efficacy results. The American Stroke Association, International Stroke Conference; 2006; Kissimmee, Florida. http://www.abstractsonline.com.
  118. Kidwell C, Starkman S, Jahan R, Alger JR, Duckwiler G, Vinuela F, et al. Pretreatment MRI penumbral pattern predicts good clinical outcome following mechanical embolectomy. Stroke. [Abstract]. 2004;35:294.

PII: S0022-510X(09)00870-3

doi: 10.1016/j.jns.2009.09.027

Journal of the Neurological Sciences
Volume 288, Issue 1 , Pages 13-24 , 15 January 2010

Article Tools

* Image Usage & Resolution